ArticleClinical and molecular hepatology2025
Correspondence to letter to the editor on "Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study".
Young Eun Chon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.